Deviation from physiologically appropriate oxygen levels alters proliferation, cytokine production and proximal antigen receptor signalling in CD4+ memory T cells

• by Elizabeth Clay, Graham R. Wallace, Stephen P. Young

• May 26, 2026

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

• by Kathryn Wighton

• May 29, 2026

• 2 min

A rapid, accessible real-time PCR approach to identify UBA1 somatic mutations in VEXAS syndrome

• by Luisa Agnello, Caterina Maria Gambino, Lidia La Barbera, Anna Masucci, Roberta Vassallo, Francesco Cacciabaudo, Mauro Midiri, Concetta Scazzone, Anna Maria Ciaccio, Giuliana Guggino, Marcello Ciaccio

• May 28, 2026

An explainable predictive machine learning model of osteopenia for perimenopausal women based on clinical data: a retrospective single-center study

• by Xiaoling Zhuo, Huixian Zeng, Huoqiang Chen, Yunlin Wang, Zhenhua Feng, Quanhui Liang

• May 29, 2026